| |
Levo OR
|
Levo ICU
|
Pvalue
|
|---|
|
(n = 28)
|
(n = 18)
|
|---|
|
Age (years)
|
66 ± 10
|
67 ± 11
|
0.535
|
|
Weight (kg)
|
82.1 ± 15.9
|
81.5 ± 15.0
|
0.928
|
|
Height (m)
|
1.76 ± 0.1
|
1.72 ± 0.1
|
0.167
|
|
Body mass index (kg/m2)
|
26.3 ± 3.9
|
27.9 ± 5.0
|
0.286
|
|
Sex (men/women)
|
22/6
|
13/5
|
0.622
|
|
Procedure
| | | |
|
CABG
|
15
|
5
|
0.114
|
|
VR
|
5
|
8
|
0.051
|
|
CABG + VR
|
8
|
5
|
0.953
|
|
NYHA III/IV
|
25
|
16
|
0.966
|
|
Coronary artery disease
|
23
|
13
|
0.426
|
|
LVEF (%)
|
31 ± 12
|
36 ± 15
|
0.233
|
|
COPD
|
9
|
5
|
0.754
|
|
Peripheral vascular disease
|
7
|
5
|
0.834
|
|
Atrial fabrillation
|
17
|
9
|
0.474
|
|
Hyperlipidaemia
|
8
|
8
|
0.270
|
|
Nicotine abuse
|
6
|
1
|
0.144
|
|
Pulmonary arterial hypertension
|
12
|
10
|
0.400
|
|
Arterial hypertension
|
13
|
9
|
0.813
|
|
Diabetes mellitus
|
16
|
12
|
0.518
|
- Data are expressed as mean ± SD, numbers or percentage. CABG, coronary arterial bypass grafting; VR, valve reconstrution and/or replacement; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; COPD, chronic obstructive pulmonary disease.
